Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012...

download Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

of 26

Transcript of Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012...

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    1/26

    Advances in Polymeric Systems for TissueEngineering and Biomedical Applications

    Rajeswari Ravichandran, Subramanian Sundarrajan,*Jayarama Reddy Venugopal, Shayanti Mukherjee, Seeram Ramakrishna*

    1. Introduction

    The prerequisites of polymer scaffold materials for tissue

    engineering applications are manifold and highly challen-

    ging. These include (i) biocompatibility of the polymer

    material (ii) the material must not elicit unnecessary

    inflammatory response (iii) the material should not

    demonstrate any adverse immune response or cytotoxicity

    (iv) similar to allmaterials in contact with human body, the

    scaffolds must be easily sterilizable to prevent infection.

    In addition, the mechanical properties of the polymeric

    scaffold must be compatible andshould notcollapse during

    surgical implantation or during the patients regular

    activities. There is an extensive list of criteria a polymer

    has to satisfy in order to be applied safely as polymer

    therapeutics or as an agent in tissue regeneration. A

    polymeric biomaterial intended for tissue engineering

    application can be characterized as a material intended to

    Review

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal,

    S. Mukherjee, S. Ramakrishna

    Healthcare and Energy Materials Laboratory, Nanoscience and

    Nanotechnology Initiative, Faculty of Engineering, National

    University of Singapore, Singapore

    E-mail: [email protected]; [email protected]

    R. Ravichandran, S. Sundarrajan, S. Ramakrishna

    Department of Mechanical Engineering, National University of

    Singapore, Singapore 117576

    The characteristics of tissue engineered scaffolds are major concerns in the quest to fabricate

    ideal scaffolds for tissue engineering applications. The polymer scaffolds employed for tissue

    engineering applications should possess multifunctional properties such as biocompatibility,

    biodegradability and favorable mechanical properties as it comes in direct contact with the

    body fluids in vivo. Additionally, the polymer system should also possess biomimetic archi-tecture and should support stem cell adhesion, proliferation and differentiation. As the

    progress in polymer technology continues, polymeric biomaterials have taken characteristics

    more closely related to that desired for tissue engineering and clinical needs. Stimuli

    responsive polymers also termed as smart biomaterials respond to stimuli such as pH,

    temperature, enzyme, antigen, glucose and electrical stimuli that are inherently present in

    living systems. This review highlights the exciting advancements in these polymeric systems

    that relate to biological and tissue engineering appli-

    cations. Additionally, several aspects of technology

    namely scaffold fabrication methods and surface

    modifications to confer biological functionality to

    the polymers have also been discussed. The ultimateobjective is to emphasize on these underutilized adap-

    tive behaviors of the polymers so that novel appli-

    cations and new generations of smart polymeric

    materials can be realized for biomedical and tissue

    engineering applications.

    286

    Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim wileyonlinelibrary.com DOI: 10.1002/mabi.201100325

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    2/26

    interface with biological systems to evaluate, treat,

    augment, repair or replace any tissue, organ or function

    of the body.[1] In tissue engineering applications the

    polymeric scaffold material serves as a biomimetic

    template for cell adhesion, proliferation, differentiation,

    extracellular matrix (ECM) formation and mineralizationthereby providing a favorable environment for the

    regeneration of damaged tissue. Similarly in the case of

    drug delivery applications, if the polymer is not a drug

    itself, it often provides a passive function as a drug

    carrier, reducing immunogenicity, toxicity or degradation,

    while improving circulation time and potentially a passive

    targetingfunction. In this case thepolymer hasto be water-

    soluble, non-toxic, non-immunogenic and it needs to be

    safe before and after the drug has been released, including

    a safe excretion. If the polymer is non-degradable (e.g.,

    polymethacrylates), the size needs to be below the renal

    threshold ensuring that it is not accumulated in the body.

    If the polymer is degradable (e.g., polyesters), the toxicity

    and/or immune response of the byproducts have to be

    taken into consideration. As the line of development

    continues, polymeric biomaterials will take on character-

    istics more closely related to that of pharmaceutical and

    clinical needs, where the polymer material is designed

    to function in a biospecific manner by interacting with

    specific biological and biochemical pathways in vivo. The

    objective of this review is to put in evidence the evolution

    and potentiality of the emerging polymer approaches and

    the advancements made to the existing polymer systems

    for tissue engineering applications. This review highlights

    the exciting developments in polymer technology thatrelate to biomedical applications. Toward these ends,

    several aspects of technology have been highlighted,

    namely scaffoldfabrication methods,surface modifications

    to confer biological functionality to the polymers and the

    advanced polymeric systems that can be employed in

    combination for several tissue engineering and biomedical

    applications.

    2. Scaffold Fabrication Techniques forBiomedical Engineering

    Current efforts in polymer scaffold fabrication techniques

    have been focused on custom designing and synthesizing

    polymers with tailored properties for specific biomedical

    applications; for instance (i) developing novel polymeric

    materials with unique chemistries to increase the

    diversity of polymer structure, (ii) developing biosynthetic

    processes for fabricating biomimetic polymer structures

    and (iii) adopting combinatorial and computational

    approaches for scaffold design. Other highly desirable

    features concerning scaffold fabrication include near-net-

    shape fabrication and scalability for cost-effective produc-

    tion. Polymers are the primary materials for scaffold

    fabrication and the requirements for following certain

    fabrication techniques has ranged from their potential

    ability to create scaffolds with controlled porosities,

    Rajeswari Ravichandran received her B.Tech in

    Biotechnology from Anna University, India. She

    then did her M.Eng in Bioengineering from

    National University of Singapore (NUS) and is

    currentlypursuingher PhDfrom NUS. Herresearch

    interests include cardiac tissue engineering, bio-materials and stem cell biology.

    Subramanian Sundarrajan graduated with an

    M.Sc. in Inorganic Chemistry from the University

    of Madras, India in 1996. Later, he worked in a

    project at Indian Institute of Science, India till

    1999. He his PhD from the University of Madras

    in2003and joined the NUS in2003and currently

    working as Senior Research Fellow and he is

    working on electrospinning of nanofibers, metal

    oxide nanoparticles and nanofibers for tissue

    regeneration applications.

    Shayanti Mukherjee completed her B.Tech inIndustrial Biotechnology fromDr. MGRUniversity,

    Chennai, India and is now pursuing her Ph.D in

    National University of Singapore, Singapore in

    myocardial tissue engineering. Her researchinter-

    est lays in translational regenerative medicine.

    Jayarama Reddy Venugopal received his PhD in

    neuroendocrinology from University of Madras,

    India. At present, he holds an appointment with

    National university of Singapore as senior research

    fellow. His research experience spans over fabrica-

    tion of biocompatible nanofibrous scaffolds for

    skin, nerve, bone, vascular and cardiac tissue

    engineering. His research interests include celland molecular biology and nanomedicine.

    Seeram Ramakrishnareceived hisPhD in Materials

    Science & Engineering from the University of

    Cambridge and General Management training

    from the Harvard University. He is a Professor

    at the department of Mechanical Engineering in

    NUS. He is a former Dean of NUS Faculty of

    Engineering from 2003 to 2008, and founding

    Co-Director of NUS Nanoscience & Nanotechnol-

    ogy Initiative from 2003 to 2010. He is a Fellow of

    major professional societies in Singapore, UK and

    USA including the American Society for Materials

    International (ASM); American Society for Mech-anical Engineers (ASME); American Institute for

    Medical & Biological Engineering (AIMBE); Institu-

    tion of Mechanical Engineers (IMechE) UK; Insti-

    tute of Materials, Minerals & Mining (IOM3) UK;

    and Institution of Engineers Singapore (IES).

    www.MaterialsViews.com

    Macromol. Biosci.2012, 12, 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 287

    Advances in Polymeric Systems for Tissue Engineering . . .

    www.mbs-journal.de

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    3/26

    encapsulation of growth factors, for controlled delivery of

    pharmaceutical agents, the removal of residual solvents

    following other fabrication methods, and to produce

    biomimetic scaffolds for tissue regeneration.[2] Materials

    fabrication and design will be more closely related to

    and actuated by specific clinical needs and biologicalphenomena. Some of the widely employed scaffold

    fabrication techniques for tissue engineering applications

    are discussed in the following section.

    2.1. Thermally Induced Phase Separation (TIPS)

    3D resorbable polymer scaffolds with very high porosities

    can be produced using TIPS technique to develop scaffolds

    with controlled macro- and microstructure architectures

    suitable for nerve, muscle, tendon, ligament, intestine,

    bone, and teeth applications.[35] This procedure requires

    the use of a solvent with a low boiling point that is easy to

    evaporate. For instance, dioxane could be used to dissolve

    aliphatic polyesters and subsequently phase separation is

    induced through the addition of a small quantity of water.

    Thisleadstotheformationofapolymer-richandapolymer-

    poor phase, which upon cooling leads to the formation of a

    porous scaffold. The polymeric scaffolds obtained via TIPS

    are highlyporouswithanisotropic tubular morphology and

    extensive pore interconnectivity. Using TIPS technique the

    pore morphology, mechanical properties, bioactivity and

    degradation rates can be controlled by varying the polymer

    concentration in solution, volume fraction of the secondary

    phase, quenching temperature and the polymer and

    solvent used.[3]

    Injectable scaffolds for tissue engineeringapplications to fill voids in damaged tissue are fascinating

    due to their ability to conform to the implant site, whereas

    preformed scaffolds require prior cognition of the defect to

    be filled and those with irregular size and shape can prove

    problematic. A microsphere network withsufficiently large

    interstices allows tissue to infiltrate the network to bear

    the mechanical loads as the scaffold degrades. A novel

    application of TIPS in tissue engineering is in the rapid

    formation of porous microspheres, wherein the pore

    morphology and the pore size can be tailored to facilitate

    surface modifications like the incorporation of bio-

    molecules. Such porous biodegradable microspheres are

    desirable for tissue engineering and drug delivery applica-

    tionsbecausetheconstituentamountofpolymerisreduced

    compared with solid microspheres, yet the scaffold volume

    is kept constant and the degradation mechanism is more

    predictable.[6] A study suggested that TIPS microspheres

    produced from liquidliquid phase separation of PLGA/

    dimethylcarbonate(DMC)andbyanemulsionroute,PLGA/

    silver-doped phosphate-basedglasses by solidliquidphase

    separation, and dispersion of protein particles by phase

    separation of PLGA/DMC in the presence of fluorescently

    labeled antibody; as a suitable candidate for localized drug

    delivery, tissue regeneration/augmentation and tissue

    engineering.[6] Chitosan and collagen are other proteins

    that have been used to fabricatemicrospheres using TIPS.[7]

    The microspheres developed by TIPS enable control over

    both the open pore structure (determined by microsphere

    size) and the internal structure, which could be matched tothe desired tissue by adjusting the processing parameters.

    A network of biologically active microspheres fabricated

    using TIPS could be applied as a tissue engineering scaffold,

    or could actas a filler material for inaccessiblesoft andhard

    tissue repair/augmentation.

    2.2. Solvent Casting and Particulate Leaching

    Solvent casting of polymeric scaffolds involves the

    dissolution of the polymer in an organic solvent, mixing

    with porogen granules like sugar, inorganic salt, paraffin

    spheres, and casting the solution into a predefined 3D

    mould. The size of the porogen particles used will affect the

    scaffold porosity, while the polymer to porogen ratio is

    directly correlated to the amount of porosity of the final

    structure. The solvent is later allowed to evaporate and the

    porogen particles are removed by leaching, following

    the main processing step. The main advantage of this

    fabrication technique is the ease of fabrication without the

    need for any specialized equipment; however organic

    solvents must be fully removed in order to avoid any

    possible damage to the cells seeded on the scaffold. A

    study reported an enhanced solvent casting/particulate

    leaching (SCPL) method developed for preparing three-

    dimensional porous polyurethane (PU) scaffolds forcardiac tissue engineering applications.[8] It involved a

    combination of SCPL with centrifugation; with the

    aim to enhance the pore uniformity and the pore

    interconnectivity. These scaffolds showed uniform distri-

    bution of the human aortic endothelial cells, useful for

    cardiac tissue engineering applications.

    2.3. Solid Freeform Fabrication Techniques (SFFT)

    Thistechniqueis employed to fabricatehighly reproducible

    scaffolds with completely interconnected porous net-

    works.[9,10] Using digital data produced by imaging soft-

    ware such as computer tomography or magnetic resonance

    imaging enables appropriate design of the polymeric

    scaffold structure.[10] Solid freeform (SFF) manufacturing

    coupled with conventional foam scaffold fabrication

    procedures (phase separation, emulsion-solvent diffusion

    or porogen leaching) may be used to fabricate materials

    with controlled micro- and macroporous architectures.

    Suchbiomimetic internal architectures may provevaluable

    for multi-tissue and structural tissue interface engineering.

    Unlike conventional computerized machining techniques

    which involve the removal of materials from a stock,

    288 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    4/26

    SFF process employs the underlying concept of layered

    manufacturing,[11] whereby three-dimensional objects

    are fabricated with layer-by-layer building via the proces-

    sing of solid sheet, liquid or powder material stocks. For

    instance, Xiong et al.[8] fabricated composites of PLLA/TCP

    with porosities of up to 90% as shown in Figure 1, withmechanical properties close to human cancellous bone by

    using low-temperature deposition based on a layer-by-layer

    manufacturing methodof SFFfabrication. Theflexibility and

    manufacturing advantages of SFF have been employed for

    biological applications ranging from the production of

    scale replicas of human bones[12] and body organs[13] to

    the advancedcustomized drugdelivery devices[14]and other

    areas of medical sciences including medical forensics.[15]

    Three-dimensional printing (3D-P) is the most widely

    investigated SFF technique for scaffold fabrication.

    Kim et al.[16] employed 3D-P with particulate leaching

    technique for creating porous scaffolds using polylactide-

    co-glycolide (PLGA) powder mixed with salt particles and a

    suitable organic solvent. Electron microscopy results

    performed 2 days after the in vitro cell culture with

    hepatocytes (HCs) revealed the successful attachment of

    largenumbersofHCsontothescaffolds.Similarly,Zeltinger

    etal.[17] employed 3D-P-fabricatedporous poly(L-lactic acid)

    (L-PLA) disc shaped scaffolds measuring 10mm (diameter)

    by 2 mm (height) to investigate the influence of pore size

    and porosity on cell adhesion, proliferation and matrix

    deposition. The scaffolds were constructed with two

    different porosities (75% and 90%) and four different pore

    size distributions (

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    5/26

    the polymer solution to create a gel. Water is then used to

    extract the solvent from the gel; the gel is cooled to a

    temperature below the glass transition temperature of the

    polymer and freeze dried under vacuum to produce a

    nanofibrous scaffold.[2022] The desired architecture can be

    obtained through the addition of various porogens topolymer solution during the phase separation process. This

    provides engineers with a significant amount of control in

    tailoring both the pore sizes and interconnectivity of the

    resultant polymeric material by altering the concentration,

    size, and geometry of the porogens used.[21] Unlike other

    techniques, phase separation is a simple process that does

    not require much specialized equipment. Besides, it is also

    easy to achieve batch-to-batch consistency; and tailoring of

    scaffold mechanical properties and architecture is easily

    achieved by varying polymer/porogen concentrations.

    However, thisfabricationprocess islimited tobeing effective

    with only a selective number of polymers and is strictly a

    laboratory scale technique.[20]

    2.5. Electrospinning

    Inthelastdecade,electrospinningtechniquehasattracteda

    great interest as it allows the fabrication of fibrous non-

    woven micro/nano fabrics for tissue engineering applica-

    tions, mainly due to the structural similarity to the tissue

    extracellular matrix (ECM). Electrospinning technique

    involves the application of high voltage to a polymeric

    solution, in order to create an electrically charged jet

    randomly collected onto a grounded target.[26,27] Electro-

    spinning is a simple and versatile method to prepare ultrathinfibersfrompolymersolutionsormelts.Itutilizesahigh

    voltage source to inject charge of a certain polarity into

    a polymer solution or melt, which is then accelerated

    toward a collector of opposite polarity. As the electrostatic

    attraction between the oppositely charged liquid and

    collector and the electrostatic repulsions between like

    charges in the liquid become stronger, the leading edge of

    the solution changes from a rounded

    meniscus to a cone (the Taylor cone). A

    fiber jet is eventually ejected from the

    Taylor cone as the electric field strength

    exceeds the surface tension of the liquid.

    The fiber jet travels through the atmo-

    sphereallowing the solvent to evaporate,

    thus leading to the deposition of solid

    polymer fibers on the collector.

    By modifying variables such as the

    distance to collector, magnitude of

    applied voltage, or solution flow rate,

    researchers can dramatically change the

    overall scaffold architecture depending

    on the desired application. The fibres

    produced by this technique usually have

    a diameter from several nanometers to a few micrometers.

    Electrospun polymer nanofibres possess many extraordin-

    ary properties including small diameters, favorable biomi-

    metic architecture, concomitant largespecificsurface areas,

    large surface to volume ratio which favors enhanced

    protein adsorption, a high degree of structural perfectionandgoodmechanicalproperties.Inordertomoreaccurately

    mimic the natural ECM, research has also examined the

    electrospinning of natural materials such as: collagen,[28]

    chitosan[29] and gelatin.[30] However, these materials often

    lack the desired physical properties or are difficult to

    electrospin on their own, which hasled to the development

    of hybrid materials, which consist of a blend of synthetic

    and natural polymers.[3032] Stitzel etal. studied the use of a

    hybrid blend of type I collagen (45%), PLGA (40%), and

    elastin (15%) to form a vascular prosthesis using electro-

    spinning.[31] The addition of PLGA was shown to improve

    mechanical properties such as burst strength and com-

    pliance of the prosthesis in comparison to scaffolds

    composed solely of type I collagen and elastin alone.

    Electrospun fibers can be oriented or arranged randomly,

    givingcontroloverboththebulkmechanicalpropertiesand

    the biological response to the scaffold. For example, in

    designing scaffolds meant to replace highly oriented tissue

    such as the medial layer of a native artery it is desirable to

    generate aligned nanofibers. In the medial layer both

    smooth muscle cells and ECM fibrils are aligned circumfer-

    entially, which allows for vasoconstriction and vasodila-

    tion in response to corresponding stimuli. Xu et al.

    developed an aligned nanofibrous scaffold using electro-

    spinning of a poly (L-lactide-co-e-caprolactone) (P(LLA-CL))(75:25) copolymer for vascular tissue engineering.[32]

    Smooth muscle cells attached and migrated along the axis

    of the aligned fibers. Furthermore, the proteins comprising

    the cytoskeleton of the smooth muscle cells were aligned

    parallel to the aligned fibers, demonstrating the cells

    proclivity to organize along oriented fiber topography.

    Figure 2 shows a SEM image of electrospun gelatin

    Figure 2. SEM image of electrospun gelatin nanofibers at a) 500x and b) 5000xmagnification.

    290 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    6/26

    nanofibers at 500x and 5000x magnification. A detailed

    review concerning the performance of nanofibrous poly-

    meric materials in guiding cells to initially adhere

    and spread over the material, as well as further triggering

    them to differentiate and secrete the appropriate ECM

    biomolecules targeted to skin, blood vessel, cartilage,muscle, adipose, nerve and bone tissue engineering

    applications is dealt elsewhere.[33] The various advantages

    and disadvantages of the scaffold fabrication techniques

    aresummarizedin Table1. Whilethe size scale,porosity and

    orientation of scaffolds fabricated by these techniques can

    be modified to influence cell functions such as adhesion,

    proliferation, and migration, even greater enhancement

    over the control of cellular function can be achieved by

    attachingbioactivemoleculesto the surface of the scaffolds

    as discussed in the following section.

    3. Surface Functionalization of PolymericMaterials for Tissue Engineering

    Over the years, several advancements in polymeric

    materials have addressed biological aspects of increased

    complexity, starting on the level of ion interactions

    and moving to growth factor and stem cell incorporation.

    The polymeric materials were extended from purely

    Table 1. Various scaffold fabrication techniques, their advantages and disadvantages and their potential applications.

    Fabrication technique Advantages Disadvantages Applications

    Thermally induced

    phase separation

    Can control the porosity

    and pore morphology

    Achievable sizes range

    from only 10 to 2000 mm

    in diameter

    Proteins and drug delivery

    and higher drug encapsulation

    efficiency

    Solvent casting

    and particulate

    leaching

    Simple operation, control

    of the pore size and

    porosity by selecting the

    particle size and the

    amount of salt particles

    Distribution of salt particles

    is often not uniform within

    the polymer solution, and

    the degree of direct contact

    between the salt particles is

    not well controlled,

    interconnectivity of pores

    in a final scaffold cannot be

    well controlled, limited

    membrane thickness, lack

    of mechanical strength,

    problems with residual

    solvent, residual porogens.

    Cardiac and vascular tissue

    engineering applications

    Solid freeform

    fabrication

    techniques

    Customized design,

    computer-controlled

    fabrication, anisotrophic

    scaffold microstructures,

    processing conditions

    Lack of mechanical strength,

    limited to small pore sizes

    Production of scale replicas

    of human bones and body

    organs to advanced

    customized drug delivery

    devices

    Phase separation Allows incorporation ofbioactive agents,

    highly porous structures

    Lack of control overmicro-architecture,

    problems with residual

    solvent, limited range

    of pore sizes

    Drug release and proteindelivery applications

    Electrospinning Easy process, High porosity,

    High surface

    area to volume ratio

    Limit range of polymers,

    lack of mechanical strength,

    problems with residual

    solvent, lack of control over

    micro-architecture

    Bone, skin, nerve and cardiac

    tissue engineering

    www.MaterialsViews.com

    Macromol. Biosci.2012, 12, 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 291

    Advances in Polymeric Systems for Tissue Engineering . . .

    www.mbs-journal.de

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    7/26

    synthetic materials to material/biologic hybrids, engi-

    neering at the same time bioactivity and biodegradability

    by imparting biological cues into the polymer. For

    instance, in order to apply biodegradable polyester based

    nanocomposite in tissue engineering, their surfaces have

    to be chemically and physically modified with theincorporation of bioactive molecules and cell binding

    proteins. This provides the desired biomimetic micro-

    environments for cell adhesion, proliferation and differ-

    entiation. Therefore, many approaches to functionalize

    the surface of biodegradable polymer scaffolds have been

    undertaken in order to introduce useful surface character-

    istics to the polymer for tissue engineering applications.

    The scaffold environment should be able to present

    and deliver combinations of biomolecules such as cell

    adhesion motifs, protein molecules, growth factors,

    angiogenic factors, differentiation factors and immuno-

    suppressive or anti-inflammatory agents.

    3.1. Stem Cells

    Stem cell incorporation into polymeric scaffolds is of

    immense potential for creating next-generation syn-

    thetic/living composite biomaterials that feature

    high adaptability to the biologicalenvironment. Scaffolds

    seeded with stem cells allow the cells to undergo

    differentiation to adapt the desired tissue engineering

    approach. This approach enables the polymeric scaffold

    surface to mimic complex biological functions leading to

    in vitro and in vivo growth of tissues and organs. Acombination of mesenchymal stem cells, growth factors,

    and bioresorbable polymers canprovide a solution for the

    treatment of difficult tendon injuries. A knitted PLGA

    matrix populated with allogeneic bone-marrow-derived

    MSCs was used to bridge Achilles tendon defects in adult

    rabbits.[34] In this study the specimens treated with MSCs

    showed a higher rate of tissue regeneration and remodel-

    ing at 2 and 4 weeks after surgery compared with the

    group treated with PLGA alone.Similarly in a recentstudy

    byourgroup,acombinationofMSCswithcardiomyocytes

    cultured on an elastomeric poly(glycerol sebacate)/

    gelatin nanofibrous scaffolds was shown to be favorable

    for the regeneration of the infarcted myocardium. In the

    study the incorporation of stem cells into the polymeric

    material induces paracrine signaling effects, reducing

    the cell death of cardiomyocytes.[35] Figure 3 shows the

    double immunostaining image for both MSC marker

    protein and cardiac marker proteins expressed by stem

    cells which have undergone cardiogenic differentiation.

    Thus the incorporation of stem cells into polymeric

    materials lead to the production of next generation

    biomimetic scaffolds for various tissue engineering

    applications.

    3.2. Biomolecules

    There is a significant scope in the application of surface

    modifications, through the use of protein biomolecules to

    provide more cues for cell adhesion, proliferation and

    differentiation. Integrins, laminin and Arg-Gly-Asp (RGD)

    proteins and also several natural proteins like collagen,gelatin and fibrinogen were shown to be essential for cell

    attachment to polymeric material surfaces devoid of any

    cell recognition sites.[36,37] The immobilization of these

    proteins to polymers not only promotes cell adhesion and

    proliferation but also increases hydrophilicity of hydro-

    phobic polymers such as aliphatic polyesters. One such

    surface functionalization for biopolymer substratesurfaces

    is attachment of RGDpeptides that isthe most effectiveand

    often employed peptide sequence for stimulating cell

    adhesion on synthetic polymer surfaces. This peptide

    sequence can interact with integrin receptors at the focal

    adhesion points. Once the RGD sequence is recognized bythe integrins, it will initiate an integrin-mediated cell

    attachment pathway and activate signal transduction

    between the cell and ECM, thus influencing various cell

    behaviors on the substrate including proliferation, differ-

    entiation, survival and migration.[38] In another study,

    Jiang et al.used a coaxial electrospinningset-up tofabricate

    biodegradable core/shell fibers with PCL as the shell and

    BSAcontainingdextranasthecore. [39]BothBSAloadingand

    its release profile could be controlled by varying the feed

    rate of the core solution, with higher feed rates giving

    higherBSA loading andacceleratedrelease. Addition of PEG

    to the shell was used to further control the release profile,

    and was shown to increase release of BSA. By varying the

    inner solution feed rate as well as the PEG content of

    the shell the authors were able to vary the release period

    from 1 week to approximately 1 month, for drug delivery

    applications.

    3.3. Growth Factors

    Scaffolds functionalized with immobilized growth factors

    is of utmost importance in several tissue engineering

    applications as the embedded growth factors (i) could

    be released in response to several cell-mediated stimuli,

    (ii) could create a highly regulated network of signaling

    molecules for mediating several biological pathways,

    (iii) able to orchestrate cell attachment, migration, organi-

    zation and proliferation finally giving rise to functional

    tissue. The focus of studies during the past decade has been

    on numerous growth factors that promote soft-tissue

    regeneration suchas platelet-derived growth factor (PDGF),

    epidermal growth factor, basic fibroblast growth factor,

    insulin-like growth factor-I, bone morphogenetic proteins

    (BMPs) and transforming growth factors.[4045] Polymeric

    systems that provide a gradual and controlled release of

    292 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    8/26

    growthfactors to thesite of injuryis of extreme importance

    for tissue repair and regeneration. Growth factors like

    BMPs were shown in in vivo studies to be osteoinductive.

    Immobilizing these growth factors on the scaffold

    surface might significantly shorten the bone healing

    process, enhance osseointegration and reduce patient

    recovery time. Chew et al. examined the release ofb-nerve

    growth factor (NGF) stabilized in BSA from a copolymer

    consisting ofe-caprolactone and ethyl ethylene phosphate

    (PCLEEP).[46] Due to its relatively hydrophobic backbone,

    PCLEEP has a slow degradation rate demonstrating a mass

    loss of approximately 7% over a 3-month period. Using this

    system, the authors observed a sustained release of NGF

    over a period of 3 months. Due to the relatively small

    amount of mass loss over this period it was inferred

    that NGF release was occurring primarily via diffusion,

    demonstrating that a biodegradable system can be used to

    obtain a desirable release profile while still eliminating the

    need for a second surgery for implant removal. A detailed

    review of various growth factors and their significance for

    tissue engineering has already been discussed.[47,48]

    3.4. Surface Modification Techniques

    Surface modification techniques such as plasma treatment,

    ion sputtering, oxidation and corona discharge affect the

    chemical and physical properties of the polymer surface

    without significantly changing the inherent bulk material

    properties. For example, using plasma processes, it is

    possibleto change thechemicalcompositionand properties

    of the polymer system such as wettability, surface energy,

    metal adhesion, refractive index, hardness, chemical

    inertness and biocompatibility.[49] Plasma techniques can

    easily be used to induce the desired groups or chains onto

    Figure 3.Dual immunocytochemical analysis for the expression of MSC marker protein CD 105 (a, d, g) and cardiac marker protein actinin(b, e, h) in the coculture samples and the merged image showing the dual expression of both CD 105 and actinin (c, f, i); on the TCP (a, b, c),gelatin nanofibers (d, e, f), and PGS/gelatin core/shell fibers (g, h, i) at 60x magnification. Nucleus stained with DAPI.

    www.MaterialsViews.com

    Macromol. Biosci.2012, 12, 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 293

    Advances in Polymeric Systems for Tissue Engineering . . .

    www.mbs-journal.de

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    9/26

    the surface of a polymer.[5052] Appropriate selection of

    the plasma source provides the introduction of diverse

    functional groups on the polymer surface to improve

    biocompatibility or to allow subsequent covalent immo-

    bilization of various bioactive cues. For instance, plasma

    treatments with oxygen, ammonia, or air can generatecarboxyl groups or amine groups on the polymer sur-

    face.[53,54] Plasma treatment affects the chemistry of the

    biodegradable polymer surface, but at the same time it

    also introduces significant changes in topography.[55,56] A

    variety of ECM protein components such as gelatin,

    collagen, laminin, and fibronectin could be immobilized

    onto the plasma treated surface to enhance cellular

    functions.[57,58] In a recent study, it was noticed that

    fibroblasts proliferation, morphology, CMFDA dye expres-

    sion and secretion of collagen were significantly improved

    on plasma-treated PLACL/gelatin scaffolds compared to

    PLACL nanofibrous scaffolds, proving that the plasma-

    treated PLACL/gelatin nanofibrous scaffold is a potential

    biocomposite material for skin tissue regeneration.[59]

    4. Advancements in Polymer Systems forCell Culture

    Living systems respond to external stimuli adapting

    themselves to changing environmental conditions. Poly-

    mer scientists recently have been trying to mimic this

    behavior for creating smart polymeric systems for tissue

    engineeringapplications.Thesesmartpolymersaredefined

    as polymers that undergo reversible large, physical orchemical changes in response to small external changes in

    the environmental conditions, such as temperature, pH,

    light, magnetic or electric field, ionic factors, biological

    molecules, etc. Smart polymers have very promising

    applications in the biomedical field as delivery systems

    of therapeutic agents, tissue engineering scaffolds, cell

    culture supports, bioseparation devices, sensors or actua-

    tors systems. Hoffman et al.[60] demonstrated, in a very

    elegant design, that theaction of an enzymatic receptor can

    be modulated when this kind of polymer isconjugated close

    to its active place. The authors were able to switch on-off

    the receptor using the transition between extended and

    coiled form of the molecule.[61] Two different kinds of

    bioconjugates including stimuli-responsive polymers can

    be prepared for biological applications by: a). Random

    polymer conjugation to lysineaminogroups of a protein. b).

    Site-specific conjugation of the polymer to genetically

    engineered specific amino acid sites. The placement of

    stimuli-sensitive polymers near the active place of a

    recognition protein can provide a highly environmental-

    sensitive system. Some of the widely employed smart

    polymeric systems have been dealt with in detail in the

    following sections.

    4.1. Nanocomposites Embedded Polymer Systems

    Nanocomposites are an efficient strategy to upgrade

    the structural and functional properties of synthetic

    polymers. Aliphatic polyesters such as polylactide (PLA),

    poly(glycolides) (PGA), poly(caprolactone) (PCL) have

    attracted wide area for their biodegradability and bio-compatibility in the human body. However all these

    desired properties cannot be achieved from a single

    polymer system. In fact, although several polymeric

    materials are available and have been investigated for

    tissue engineering, no single biodegradable polymer can

    meet all the requirements for biomedical applications.

    Therefore, the design of multi-component polymer

    systems represents a viable strategy in order to

    develop innovative multifunctional polymeric materials.

    A consequence has been the introduction of organic

    and inorganic nanofillers into biodegradable polymers

    to produce nanocomposites based on hydroxyapatite,metal nanoparticles or carbon nanotructures, to prepare

    advanced polymeric systems with enhanced properties.

    This combination of bioresorbable polymers and

    nanostructures opens new perspectives in the

    application of nanomaterials for biomedical

    applications with desirable mechanical, thermal and elec-

    trical properties.

    4.1.1. Polymer/HA Nanocomposites

    Natural bone matrix is an organic/inorganic composite

    material of collagen and apatites. Composite material

    systems based on inorganic nanoparticles, showed astrongly enhanced polymer degradation rate when com-

    pared to pure polymer systems. Studies have shown that

    tricalcium phosphate filled polymers showed deposition of

    small, 10 nm sized hydroxyapatite crystals on the surface

    of the PLGA polymer composite, while for pure PLGA/

    nanohydroxyapatite formation was observed during

    degradation, indicative of enhanced osteoconductive

    properties of PLGA nanocomposites. The fast degradation

    and the superior osteoconductivity make these nanocom-

    posites a promising material for application in ortho-

    pedics.[62,63] These polymer/HA nanocomposites can also

    be surface modified for the release of biomolecules. For

    instance, Nie and Wang examined the release of DNA from

    electrospun scaffolds consisting of a blend of PLGA and

    hydroxyapatite (HAp) with various HAp contents (0%, 5%,

    and 10%) for bone tissue engineering applications.[64] DNA

    wasincorporated into thescaffolds in three ways: (1)naked

    DNA, (2) adsorption of DNA/chitosan nanoparticles onto

    scaffoldsafter scaffold fabrication by dripping, or (3)blend-

    ing DNA/chitosan nanoparticles with the PLGA/HAp

    solution prior to electrospinning. They noticed that higher

    HAp contents led to faster DNA release for both free and

    encapsulated DNA. This may be due to the hydrophilic

    294 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    10/26

    nature of HAp, which caused the DNA/chitosan bind to

    HAp particles in the presence of dichloromethane

    during the emulsion procedure. These techniques not only

    increase encapsulation efficiency, as was noted by the

    authors, but it would also increase the release rate.

    As the HAp nanoparticles diffuse out of the PLGA fibersthey leave pores through which the DNA/chitosan

    particles can easily diffuse through the scaffolds.

    The authors noted that encapsulated DNA/chitosan nano-

    particles enhanced transfection efficiency leading to

    higher cell attachment and viability in an in vitro study.

    Thus, it was demonstrated that the encapsulation of

    DNA/chitosan nanoparticles in PLGA/HAp electrospun

    scaffolds has the potential to augment bone tissue

    regeneration. In a recent study by our group n-HA was

    precipitated by calcium-phosphate dipping method on

    PLLA/PBLG/Col scaffolds. The incorporation of n-HA drives

    the adipose derived stem cells to osteogenic lineage on

    these scaffolds, in the absence of any induction medium,

    for bone tissue engineering.[65]

    4.1.2. Polymer Embedded Nanoparticles

    Silver (Ag) has been known to have a disinfecting effect

    and has been applied in traditional medicines. Several

    salts of Ag and their derivatives are commercially

    employed as antimicrobial agents. Hence, Ag/polymer

    nanocomposites have been investigated for their anti-

    bacterial property.[66,67] Theuseofnanoparticleshasbeen

    limited by difficulties associated with handling and

    processing of nanoparticles. Embedding of nanoparticlesinto biodegradable polymer matrices represents a valid

    solution to these stabilization problems and permits a

    controlled effect.[68] For instance, Liang et al. examined

    the incorporation of DNA into PLGA scaffolds fabricated

    by electrospinning.[69] Plasmid DNA was condensed in a

    poor solvent mixture, and was then encapsulated in

    micelles composed of a triblock copolymer (PLA-PEG-PLA)

    givingencapsulatedDNAnanoparticles.

    The micelles were then dissolved in a

    solution of DMF with PLGA and electro-

    spun, resultingin theformation of PLGA

    fibers containing encapsulated DNA

    nanoparticles. The DNA was encapsu-

    lated in the PLA-PEG-PLA triblock copo-

    lymer in order to protect it from

    degradation during electrospinning

    with the PLGA copolymer. An in vitro

    release study demonstrated that

    approximately 20% of the encapsulated

    DNA was released after a period of 7 d.

    Such systems are very useful for

    gene delivery anddrug delivery applica-

    tions.

    4.1.3. Polymers Incorporating Carbon Nanostructures

    Polymers incorporating carbon nanostructures have been

    investigated by several groups for a variety of biomedical

    applications.[7072] Carbon nanotubes (CNT) have the

    potential to provide the needed structural reinforcement

    for biomedical polymer scaffold. By dispersing a smallfraction of carbon nanotubes into a polymer, significant

    improvementsin the polymer/CNT composites mechanical

    strength has been observed. The role of the interface

    between the CNT and polymer matrix is essential in

    transferring the load from the polymer to the nanotubes,

    thereby enhancing the mechanical and electricalproperties

    of the composite. The electrical conductivity of CNT based

    nanocompositesis a usefultoolin order todirect cell growth

    and cell differentiation since they can conduct electrical

    stimulus into the desired tissue, thereby stimulating the

    healing process in nerve, bone and cardiac tissue engineer-

    ing applications. For example when an alternating currentis applied to the nanocomposites of poly(lactic acid) and

    MWCNTs, it showed increased osteoblast proliferation and

    calcium production, favorable for bone regeneration as

    shown in Figures 4a and b respectively. [73]

    4.2. Polymer Blended Hybrid Systems

    When a singlepolymerdoes nothave theproperties desired

    for a tissue engineering application, a copolymer or blend

    (simple mixture) of polymers may be employed to achieve

    the desired properties. Studies have shown that PLA:PCL

    blends and copolymers possess great solvent flexibility andalso exhibit a percent increase in elasticity while main-

    taining an ultimate tensile strength that is analogous to

    that of pure PLA scaffolds. It was shown that by adding a

    small amount of PCL (as little as 5 wt%) to PLA, the strain to

    failure of a scaffold increased from less than 25% to

    more than 200%.[26] Similarly, Kwon et al. successfully

    Figure 4.A) Osteoblast proliferation under electrical stimulation: & without electricalstimulation; & with electrical stimulation. Values are mean SEM; n4; p

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    11/26

    electrospun poly(L-lactide-co-e-caprolactone) (PLCL) at

    various weight percents from methylene chloride in ratios

    of 70:30 (9wt%), 50:50 (7wt%), and 30:70 (11 wt%).

    It was found that at 25 8C the 70:30 ratio was a hard solid,

    the 50:50 ratio was an elastomer, while the 30:70 ratio

    was a gummy solid. The two ratios that resulted in fibrousscaffolds, 70:30 and 50:50, were determined to have a

    Youngs modulus of 14.2 and 0.8MPa, respectively,[74]

    showing a great deal of promise for use as an arterial graft.

    This is because an engineered vascular graft must be

    strong enough to accommodate a large pressure increase

    while having enough elasticity to passively expand to

    allow blood flow downstream. Similarly in another study

    Xu et al. electrospun a nanofibrous scaffold of P(LLA-CL)

    (75:25). This scaffold exhibited a tensile modulus of

    156 MPa, tensile strength of 5 MPa, and strain at break of

    127%. This compares favorably to the mechanical proper-

    ties of native coronary artery having a tensile strength of

    1.4011.14 MPa and a strain at break of 4599%.[75] As is

    true with copolymers, blending of natural polymers and/or

    synthetic polymers serves to enable further capability of

    tuning a material to attain the desired properties for

    tissue engineering applications. For instance, Huang et al.

    electrospun collagen type I and poly(ethylene oxide) to

    tailor fiber morphology and mechanical properties of

    scaffolds.[76] Additionally collagenGAG scaffold has been

    utilized extensively as dermal regeneration templateswith

    unprecedented biological activity to achieve enhanced

    healing response.[77,78]

    4.3. Stimuli-responsive Polymers

    Stimuli-responsive polymers are also termed as smart

    polymers. Interest in stimuli-responsive polymers has

    persisted over many decades, and a great deal of effort

    has been crafted to fabricate new smart materials. Stimuli-

    responsive polymers show an acute change in properties

    upon a slight change in environmental condition. This

    property can be utilized for the preparation of smart

    polymeric systems, which mimic biological response

    behavior to a certain extent. Stimuli-responsive polymers

    mimic biological systems in a primitive way where an

    external stimulus results in a change in properties. This

    can be a change in conformation, change in solubility,

    alteration of the hydrophilic/hydrophobic balance or

    release of biomolecules or combination of two or more

    responses. Many advances in stimuli response polymers

    are advantageous in the biomedical fields due to their

    specificity and their ability to respond to stimuli that

    are inherently present in vivo. The physical or chemical

    stimulus that triggers specific responses is limited to the

    formation or destruction of secondary forces (hydrogen

    bonding, hydrophobic effects, electrostatic interactions,

    etc.), simple reactions (e.g., acidbase reactions) of moieties

    on the polymer backbone, and/or osmotic pressure

    differentials that result from such phenomena.[79] Besides,

    theresponsecanalso beexpandedto include more dramatic

    alterations to the polymeric structure. For instance,

    degradation of polymeric hydrogels upon specific stimulus

    can occur by reversible or irreversible bond breakage of thepolymeric backbone or cross-linking groups. Such systems

    may facilitate the application of smart polymers in drug

    delivery, diagnostics, separations and other clinical appli-

    cations. The major advantage of these polymer systems is

    their ability to apply these stimuli in a non-invasive

    manner in living body. The stimuli may occur internally

    (such as change in pH or temperature) or externally

    (external stimuli such as magnetic or electric field, light

    and ultrasound). Figure 5 showsa schematicrepresentation

    of the various stimuli and their responses. [79]

    4.4. Conducting Polymers

    Conducting polymers (CPs) have attracted much interest as

    suitable matrices for biomolecules owing to their high

    electronic and ionic conductivities, which has been used to

    enhance the stability, speed and sensitivity of various

    biomedical devices. The electrically active tissues like the

    brain, heart and skeletal muscle provide opportunities to

    couple electronic devices and computers with human or

    animal tissues to create therapeutic bodymachine inter-

    faces. The conductive and semiconducting properties of CPs

    make them an important class of materials related to such

    applications. The origin of electrical conduction in CPs has

    been ascribed to the formation of nonlinear defects suchas solitons, polarons or bipolarons formed during either

    doping or polymerization of a monomer.[80] For example,

    Abidian et al. has demonstrated the use of the CPs

    polypyrrole (PPy) and poly(3,4-ethylenedioxythiophene)

    (PEDOT) for nerve tissue engineering applications, by

    culturing neuronal cells using an in vitro dorsal root

    ganglion model.[81] Electrical stimulation with neural

    electrodes is used clinically to improve conditions such as

    hearing loss(cochlearimplants). It wasfound that, whenPPy

    CP was coated onto cultured substrates on which cochlear

    explants were cultured, the neurite growth improved upon

    the incorporation of neurotrophins like NT-3 and brain-

    Figure 5.Potential stimuli and responses of synthetic polymers.

    296 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    12/26

    derived neurotrophic factor (BDNF). Such CP-based smart

    biomaterials provide a biocompatible substrate to help

    protect auditory neurons from degradation after sensor

    neural hearing loss and encourage neurite outgrowth

    towards the electrodes.[82] Conductive neural interfaces

    tailored forcellinteraction by surfacefunctionalization withincorporation of bioactive factors produce superior neuro-

    prosthetic devices with improved charge transfer capabil-

    ities. A study examined the effect of entrapping NGF within

    the CP PEDOT during electrodeposition to create a polymer

    capable of stimulating neurite outgrowth from proximal

    neural tissue.[83] The incorporation of NGF can modify the

    biological interactions of the electrode without compromis-

    ing on the conductive properties. Another study demon-

    strated the use of PEDOT nanotubes polymerized on top of

    electrospun PLGA nanofibres for the potential release of the

    drug dexamethasone. Here, dexamethasone was incorpo-

    rated within the PLGA nanofibers and then PEDOT was

    polymerized around the dexamethasone-loaded PLGA

    nanofibers. As the PLGA fibres degraded, dexamethasone

    molecules remained inside the PEDOT nanotubes. These

    PEDOT nanotubes favored controlled release upon electrical

    stimulation.ThiswasbecauseofthechangeinvolumeofthePEDOT nanotube upon electrical stimulation owing to the

    expulsionofanions.Figure6demonstratestheincorporation

    and release mechanism of dexamethasone from PEDOT

    nanotubes due to electrical stimulation.[84] For cardiovas-

    cularapplications,Lietal.hasdemonstratedthepotentialfor

    using PANIas anelectroactivepolymer. Theystudiedvarious

    advancements in CPs by covalently attaching oligopeptides

    to PANI and electrospinning PANIgelatin blend nanofiber

    scaffold. These scaffolds were analyzed as potential candi-

    dates for cardiac tissue engineering applications using H9c2

    myoblast cells.[85] A detailed review on the application of

    Figure 6. Schematic illustration of the controlled release of dexamethasone: A) dexamethasone-loaded electrospun PLGA, B) hydrolyticdegradation of PLGA fibers leading to release of the drug, and C) electrochemical deposition of PEDOT around the dexamethasone-loadedelectrospun PLGA fiber slows down the release of dexamethasone (D). E) PEDOT nanotubes in a neutral electrical condition. F) Externalelectrical stimulation controls the release of dexamethasone from the PEDOT nanotubes due to contraction or expansion of the PEDOT. Byapplying a positive voltage, electrons are injected into the chains and positive charges in the polymer chains are compensated. To maintainoverall charge neutrality, counterions are expelled towards the solution and the nanotubes contract. This shrinkage causes the drugs tocome out of the ends of tubes. G) Cumulative mass release of dexamethasone from: PLGA nanoscale fibers (a), PEDOT-coated PLGAnanoscale fibers (b) without electrical stimulation, and PEDOT-coated PLGA nanoscale fibers with electrical stimulation of 1 V applied at thefive specific times indicated by the circled data points (c). H) UV absorption of dexamethasone-loaded PEDOT nanotubes after 16 h (a), 87 h(b), 160 h (c), and 730 h (d). The UV spectra of dexamethasone have peaks at a wavelength of 237nm. Data are shown with a standarddeviation (n 15 for each case).

    www.MaterialsViews.com

    Macromol. Biosci.2012, 12, 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 297

    Advances in Polymeric Systems for Tissue Engineering . . .

    www.mbs-journal.de

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    13/26

    conductingpolymer for biomedical applications has already

    been discussed elsewhere.[86] CPs thus represents a class of

    smart polymeric materials that provides an excellent

    opportunity for fabricating highly selective, biocompatible,

    specific, economic and handy biomedical devices. However,

    challenges facing CPs include poor stability and mechanicalproperties as well as poor control of the mobility,

    concentration and presentation of bioactive molecules.

    4.5. Glucose-responsive Polymers

    While a variety of polymer systems have been reported for

    diagnostic applications, polymers that respond to glucose

    have received considerable recognition because of their

    potential application in both glucose sensing and insulin

    delivery applications. Diabetes mellitus, commonly

    referred to as diabetes, is a chronic disease characterized

    by deficient production of insulin. Treatment for diabetic

    patients generally involves regular monitoring of blood

    sugar concentrations and subcutaneously administering

    insulin every day. This need for continuous patient

    vigilance often leads to poor compliance with the

    prescribed treatment. One potential route proposed taking

    advantage of the advancements made in polymer systems,

    is the developmentof smart delivery of polymer systems in

    whichinsulindeliveryisautomaticallytriggeredbyarisein

    blood glucose levels in vivo. While a variety of approaches

    can be visualized to achieve this objective, considerable

    research by material scientists has been dedicated to

    developing self-regulated insulin delivery systems based

    on glucose-responsive polymers.[87]

    The majority of reportsdetailing glucose-responsive polymers are based on the

    GOx-catalyzed reaction of glucose with oxygen. Typically,

    glucose-sensitivityisnotduetodirectinteractionofglucose

    with the glucose responsive polymer, but rather by the

    response of polymer to the byproducts that result from

    the enzymatic oxidationof glucose. The enzymatic reaction

    of GOx on glucose is highlyspecific and leads to byproducts

    suchasgluconicacidandH2O2. Therefore, theincorporation

    of a polymer that responds to either of these byproducts

    can indirectly trigger a glucose-responsive system. Another

    type of glucose-responsive system as reported by Brownlee

    and Cerami utilizes competitive binding of glucose with

    glycopolymerlectin complexes.[88] Such glucose responsive

    polymers are of potential importance for diabetic patients

    owing to their specific insulin delivery applications.

    4.6. pH responsive Polymers

    pH-sensitive polymersare polyelectrolytes that bear in their

    structure weak acidic or basic groups that either accept or

    releaseprotonsin responseto changesin environmental pH.

    Different organs, tissues and cellular compartments may

    have large differences in pH, which makes the pH a suitable

    stimulus for biological applications. When weak acids

    (carboxylic acids, phosphoric acid) and bases (amines) are

    linkedto the polymer structure,they exhibit a change in the

    ionisation state upon variation of the pH. This leads to a

    conformational change in thecaseof solublepolymers and a

    change in the swelling behavior is observed in the case ofhydrogels. The pH range that a reversible phase transition

    occurs can be generally modulated by two strategies:

    1. Selecting the ionizable moiety with a pKa matching the

    desired pH range. Therefore, the proper selection

    between polyacid or polybase should be considered

    for the desired application.

    2. Incorporating hydrophobic moieties into the polymer

    backbone and controlling their nature, amount and

    distribution. When ionizable groups become neutral

    non-ionized- and electrostatic repulsion forces disappear

    within the polymer network, hydrophobic interactions

    dominate. The introduction of a more hydrophobic

    moiety can offer a more compact conformation in the

    uncharged state and a more accused phase transition.

    Ionisable polymers with a pKa value between 3 and 10

    are ideal candidates for pH-responsive systems. Some of

    the most widely studied pH responsive polymers are

    poly(acrylamide), polyacrylic acid, poly(methacrylic acid),

    poly(dimethylaminoethyl methacrylate) (PDEAEMA),

    poly(dimethylaminoethyl methacrylate) (PDMAEMA). For

    example, the change in pH along the gastro-intestinal

    tract[89] from acidic in the stomach (pH 2) to basic in the

    intestine (pH 58) has to be considered for oral deliveryof any kind of biomolocule, but there are also other, more

    subtle changes within different tissues in the body.

    Polymers are usually taken up into cells by fluid-phase

    pinocytosis or receptor-mediated endocytosis. Within the

    early endosome towards the lysosomes the pH drops from

    6.2 to 5.0 giving a large change in proton concentration

    inside these compartments. This drop in pH has been

    utilizedin orderto release biomoleculesfrom thelysosomes

    tothecytosol.[90] Intracellular delivery of oligo/poly(nucleic

    acids) usually uses cationic polymers, which complex the

    negatively charged nucleic acids. These cationic polymers

    are then deprotonated within the endosomes, which

    triggers endosome membrane disruption and release into

    the cytosol before reaching lysosome with its hydrolytic

    enzymes as shown in Figure 7.[91] Thus, tailoring the

    protonation/deprotonation by altering the polymer struc-

    ture can largely allow fine-tuning of the response in a

    specific compartment with respect to the change in pH.

    Similar to glucose responsive polymers, a pH responsive

    polymer can also be applied for insulin delivery applica-

    tions. For example a pH responsive polymer loaded or

    conjugated with GOx, triggers the GOx-catalyzed reaction.

    The gluconic acid byproduct that results from the reaction

    298 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    14/26

    with glucose induces a response in the pH-responsive

    macromolecule, thereby triggering the release of insulin

    biomolecule. For applications specifically intended for

    diabetes therapy, the pH-response generally causes swel-ling or collapse of the polymer matrix, releasing insulin.

    Imanishi and co-workers have reported the covalent

    modification of a cellulose film with GOx-conjugated

    poly(acrylic acid) (PAA) for insulin delivery applications.[92]

    Duncan et al. designed poly(amidoamine)s by combining

    both positive and negative charges within the polymer

    backbone.[93] On one side of which a very unique profile in

    size changes upon protonation/deprotonation was found

    with neutron scattering and NMR experiments.[94] The

    amphoteric backbone yields an expanded shape at low pH,

    which slowly collapsed when neutral pH is approached.

    This seems to be the reason that these polymers exhibit

    endosomolytic properties, which makes them very inter-

    esting candidates in cancer therapy, e.g. delivery of non-

    permeant toxins like gelonin. The pH-responsive swelling

    and collapsing behavior has been used to induce controlled

    release of model compounds like caffeine,[95] drugs like

    indomethacin,[96] or cationic proteins like lysozome.[95,97]

    For instance, Poly(L-histidine)-b-PEG in combination with

    PLLA-b-PEG and adriamycin as drug was studied for an

    extracellular tumor targeting. The system shows a very

    sharp transition from non-protonated and hydrophobic

    at pH 7.4, where the mixed micelles are stable, to ionized

    and micelle-destabilizing at pH 6.6.

    Adriamycin is rapidly released from the

    micelles at this pH value.[98] Several other

    groups have developed polymeric pro-

    drugs (polymers in which the drug is

    covalently attached to the macromole-cular chain) susceptible to hydrolytic

    cleavage dependent upon the pH and

    hence suitable for colon drug delivery.

    This is the case of poly(N-metha-

    cryloylaminoethyl5-aminosalycilamide)

    or poly(methacryloylethoxyethyl 5-amino-

    salycilic acid)[99] or the copolymeric

    system developed based on 2-acryl-

    amido-2-methylpropane sulfonic acid

    (AMPS) and a methacrylic derivative of

    an antiaggregant drug called Triflu-

    sal.[100] The system depends on colonic

    microflora for liberation of entrapped

    drug, which seems most suitable, i.e.,

    glycosidase activity of the colonic micro-

    flora is responsible for liberation of drugs

    from glycosidic prodrugs and the pre-

    sence of azoreductase from the anaerobic

    bacteria of the colon plays a main role

    in the release of drug from azo bound

    prodrugs.[101,102] Researchers have

    designed more sophisticated pH-sensitive polymers in

    order to take advantage of the pH changes that occur in

    nature. These materials are inspired by living organisms

    trying to mimic their response mechanisms. For instance,Sauer et al.[103] reported the synthesis of pH-sensitive

    hollow nanocontainers inspired in virion particles. The

    poly(acrylic acid) vehicles were synthesized by vesicular

    polymerization and emulsion polymerization. These nano-

    capsules combined the protective ability of the nanocon-

    tainers in combination with controlled permeability and

    therefore can be used to trigger the release of encapsulated

    materials from the inner core. Kataoka[104] recently

    communicated the development of polymeric micelles

    as nanocarriers for gene and drug delivery based on

    doxorubicin-conjugated block copolymer poly(ethylene

    glycol)-poly(aspartame hydrazinedoxorubicin) [(PEG-

    p(AspHid-dox)]. The polymer retained drugs and genes at

    physiological pH and released the drugs as pH decrease

    below 6.0.

    Another most promising application of pH-sensitive

    polymers is as nonviral gene carriers. Naked DNA is very

    difficult to incorporate into thecellsbecause it is negatively

    charged and it has a very large size at physiological

    conditions. Godbey and Mikos reviewed some of the

    advances in non-viral gene delivery research[105] describing

    the use of poly- (ethylenimine) (PEI) and poly(L-lysine)

    (PLL) as two of the most successful candidates for this

    Figure 7. Schematic of DNA condensation and encapsulation into polymeric depotsystems. A) DNA complexation with cationic polymers leads to the formation ofnanometer sized polyplexes. B) Condensed or uncondensed DNA can be encapsulatedinto polymeric scaffolds for sustained delivery.

    www.MaterialsViews.com

    Macromol. Biosci.2012, 12, 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 299

    Advances in Polymeric Systems for Tissue Engineering . . .

    www.mbs-journal.de

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    15/26

    application. PEI is a highly polycationic

    synthetic polymer that condense DNA in

    solution, forming complexes that are

    directly endocytosed by several cell

    types. Chitosan, a biocompatible and

    resorbable cationic aminopolysacchar-ide, has also extensively been used as

    DNA carrier.[106,107] Lim et al.[108] pre-

    pared a self-destroying, biodegradable,

    polycationic polyester, poly(trans-4-

    hydroxy-L-proline ester) (PHP ester), with

    hydroxyproline, a major constituent of

    collagen, gelatin, and other proteins,

    as a repeating unit. PHP ester formed

    soluble polymer/DNA complexes with

    average diameters of less than 200 nm.

    These complexes could transfect the

    mammalian cells, being comparable to

    the transfection obtained with PLL, the

    most commonpolymer for gene delivery,

    at suitable pH conditions.

    4.7. Enzyme-responsive Polymers

    A relativelynew area of research in polymeric systemsis the

    design of materials that undergo macroscopic property

    changes when triggered by selective enzymatic reac-

    tions.[109,110] These polymeric systems consists of the

    following characteristics (i) sensitivity of this system is

    unique because enzymes are highly target specific (ii) they

    can operate even under mild conditions in vivo, and (iii) arevital components in many biological pathways. Enzyme-

    responsive polymericmaterialsare composed of an enzyme-

    sensitive substrate and another component that directs or

    controls interactions that lead to macroscopic property

    variations.[110] Catalytic reaction of an enzyme on a

    substrate can lead to changes in geometry, supramolecular

    architectures, swelling/collapse of gels, or variations of

    surface characteristics.[110] Xu and co-workers reported the

    use of enzymatic dephosphorylation to induce a solgel

    transition. In the reaction sequence the small molecule

    fluorenylmethyloxycarbonyl (FMOC)-tyrosine phosphate

    was exposed to a phosphatase, and the resulting removal

    of phosphate groups led to a reduction in electrostatic

    repulsions, supramolecular assembly and eventual gelation

    of the polymer system.[111,112]Figure 8 illustratesthe design

    of a visual assay, wherein the precursor, which acts as the

    substrate of an enzyme, transforms into a hydrogelator

    when the enzyme catalyzes its conversion. Then, the self-

    assembly of the hydrogelators in water induces the

    formation of hydrogel. When inhibitors competitively bind

    with the enzyme active site and block the conversion of the

    precursor catalyzed by the enzyme, no hydrogel forms,

    asshowninFigure8. [112] Inasimilarexample,Kaplanandco-

    workers reported the modification of a genetically engi-

    neered variant of spider dragline silk via enzymatic

    phosphorylation and dephosphorylation.[113] Enzyme-

    responsive polymers upon exposure to a specific enzyme,

    undergoes changesin their macroscopic properties owing to

    the creation of new covalent linkages. For instance, Ulijin

    and co-workers used proteases to cause self-assembly of

    polymeric hydrogels via reversedhydrolysis of peptides.[114]

    Transglutaminase, a blood clottingenzyme, hasthe abilitytocross-link the side chains of lysine (Lys) residues with

    glutamine (Gln) residueswithin oracross peptidechains.[110]

    This behavior was exploited by Griffith and Sperindefor the

    synthesis of hydrogels of cross-linked functionalized PEG

    and lysine-containing polypeptides.[115,116]

    4.8. Temperature-responsive Polymers

    Temperature-responsive polymers and hydrogels exhibit a

    volume phase transition at a certain temperature, which

    causes a sudden change in the solvation state. When

    hydrogels are prepared by cross-linking temperature-

    sensitive polymers, the temperature sensitivity in water

    results in changes in the polymer hydration degree. Below

    the transition temperature the polymer swells up to

    equilibrium hydration degree, being in an expanded state.

    By increasing thetemperature above thetransition hydrogel

    deswells to a collapsed state. This transition is usually

    reversible and can be applied in a pulsatile manner making

    the polymer to behave as an on-off system when the

    stimulus is applied or removed. Polymers, which become

    insoluble upon heating, have a lower critical solution

    temperature (LCST). Systems, which become soluble upon

    Figure 8. The illustration of the design for identifying inhibitors of an enzyme byhydrogelation.

    300 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    16/26

    heating, have an upper critical solutiontemperature (UCST).

    The change in the hydration state, within the aqueous

    environment as the human body, causes the volume phase

    transition, where intra- and intermolecular hydrogen

    bonding of the polymer molecules are favored compared

    to a solubilisation by water. Typical LCSTpolymersarebasedonN-isopropylacrylamide (NIPAM),[117,118]N,N-diethylacry-

    lamide (DEAM),[119] methylvinylether (MVE),[120,121] andN-

    vinylcaprolactam (NVCl)[122,123] as monomers. A typical

    UCST systemis based on a combination of acrylamide (AAm)

    and acrylic acid (AAc).[124] Most biomedical applications use

    the change from room temperature to body temperature in

    order to induce a change in the physical properties for e.g.

    gelation, especially in applications using injectable biode-

    gradable scaffolds. Polymers with LCST have been tested in

    controlled drug delivery matrices and in on-off release

    profilesinresponsetoastepwisetemperaturechange.Inthis

    sense, polyNIPAAm hydrogels form a thick skin on their

    surface above the LCST in the collapsed state, which reduces

    the transport of bioactive molecules out of the hydrogels.

    NIPAAm has also been copolymerized with alkyl methacry-

    lates in order to increase the hydrogels mechanical proper-

    ties, without compromising on the temperature sensitivity.

    Poly(NIPAAm-co-butyl methacrylate) (poly(NIPAAm-co-

    BM))was studied forthe deliveryof insulinin a temperature

    on-off profile, below and above the LCST that in this system

    wasloweredtoabout258C.[125]The temperature-responsive

    polymers have the transition temperature in the region

    2040 8C, which is interesting for biomedical applications.

    However the transition temperature can be strongly

    dependent on factors such as solvent quality, salt concen-tration and molecular weight. PNIPAM is a very interesting

    temperature-responsive material, having good biocompat-

    ibilityand thepositionof the LCST at 3233 8C,whichisideal

    for biological applications. The LCST of PNIPAM is indepen-

    dent of the molecular weight and the concentration,[126]but

    it can be changed upon shifting the hydrophilic/hydro-

    phobic balance, by copolymerization with a second mono-

    mer. Hydrophobic co-monomers increase the LCST, whereas

    hydrophilic co-monomers have the opposite effect.[127,128]

    PNIPAM copolymers have been mainly studied for cardiac

    tissue engineering and oral delivery of biomolecules like

    calcitonin and insulin. In the latter case, the peptide or

    hormoneisimmobilizedinPNIPAMbeads,whichstaystable

    while passing through the stomach. Then in the alkaline

    intestine the beads disintegrate and the drug is released.

    Serres et al.[129] and Ramkisson-Ganorkar et al.[130] synthe-

    sized P(NIPAM-co-BMA-co-AAc) for the intestinal delivery of

    human calcitonin. Meanwhile, Kim et al. investigated the

    delivery of insulin.[131] In both cases the combination of

    the hydrophobic BMA moiety (butylmethacrylate) and

    acrylic acid (AAc), which is non-ionized at low pH, prevents

    disintegration of the beads in the acidic environment of the

    stomach. At elevated pH the beads disintegrated due to the

    solubilisation by the now ionized AAc. Thus in this case

    besides temperature, the pH also plays an important role in

    stimulating the drug release. Besides PNIPAM, Poly(methyl

    vinyl ether) also has a transition temperature exactly at

    37 8C, which makes it very interesting for biomedical

    application. Poly(N-vinyl caprolactam) (PVCa) has not beenstudied as intensively as PNIPAM, but it also possesses very

    interesting properties for medical and biotechnological

    applications, e.g. solubility in water and organic solvents,

    biocompatibility, high absorption ability and a transition

    temperature within the settings of these applications

    (338C).[123] Several approaches have been performed in the

    tissueengineering fieldas temperature sensitive scaffolds or

    surface modifications for the manipulation of cell sheets.

    Poly(NIPAAm-co-acrylic acid) (poly(NIPAAm-co-AA)) gels

    have been applied as extracellular matrix for pancreatic

    islets in biohydrid pancreas.[132]

    4.9. Antigen-responsive Polymers

    Similar to enzymatic reactions, antigenantibody interac-

    tions are also highly specific and are associated with

    complex immune responses that help to recognize any

    foreign bodies in the blood stream. Binding reaction

    between antigens and antibodies can rely on a variety of

    non-covalent interactions, such as hydrogen bonding, van-

    der-Waals forces, and electrostatic and hydrophobic

    interactions. Antibodies are employed in a number of

    immunological assays for the detection and measurement

    of biological and non-biological substances,[133] and the

    highaffinity and targetspecificity of theirinteractions with

    antigens have been harnessed to yield a variety of antigen-

    responsive synthetic polymeric systems for biological

    applications. In most cases, antigenantibody binding

    has been used to induce responses in polymeric systems

    prepared by either physically entrapping antibodies or

    antigensin networks, chemicalconjugation of theantibody

    or antigen to the network, or using antigenantibody pairs

    as reversible cross-linkers within networks.[134] Miyata

    et al. prepared antigen-sensitive hydrogels by coupling

    rabbit immunoglobulin G (Rabbit IgG) to N-succinimidy-

    lacrylate(NSA). The modified monomer was polymerized in

    the presence of goat anti-rabbit IgG as an antibody and

    acrylamide, which results in the formation of a hydrogelcross-linked both covalently and by antigenantibody

    interactions. Upon the addition of rabbit IgG as a free

    antigen, competitive binding of the goat anti-rabbit IgG

    antibodies resulted in the breakage of antigenantibody

    cross-linkers and a change in the morphology of the

    hydrogel characterized by swelling of the hydrogel.[135]

    4.10. Redox/thiol-responsive Polymers

    Redox/thiol sensitive polymers are another class of

    advanced polymers that are of immense importance in

    www.MaterialsViews.com

    Macromol. Biosci.2012, 12, 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 301

    Advances in Polymeric Systems for Tissue Engineering . . .

    www.mbs-journal.de

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    17/26

    bioengineering applications especially in the field of

    controlled drug delivery.[136,137] The interconversion of

    thiols and disulfides is a key step in many biological

    processes as it plays a significant role in the stability and

    rigidity of native proteins in living cells.[138] Since disulfide

    bondscanbereversiblyconvertedtothiolswhenexposedtovarious reducing agents and/orundergo disulfide exchange

    in the presence of other thiols, polymers containing

    disulfide linkages can be considered for both redox- and

    thiol-responsive applications.[139,140] For instance, Glu-

    tathione (GSH), is the most abundant reducing agent in

    living cells. It has an intracellular concentration of about

    10 mM, whereas an extracellular concentration of about

    0.002mMin the cell exterior.[141] This significant variation

    in concentration has been utilized to design thiol/redox-

    responsive polymer drug delivery systems that specifically

    release therapeutics into cells. For example, Lee and co-

    workers synthesized polymer micelles with shells cross-

    linked via thiol-reducible disulfide bonds as shown in

    Figure 9. These served as carriers that preferentially release

    anticancer drugs under reducing conditions typical of

    cancer tissues.[142]

    4.11. Shape Memory Polymers

    Shape memory polymers (SMPs) can rapidly change their

    shapes from a temporary shape to their permanent shapes

    under appropriate stimulus such as temperature, light,

    electric field, magnetic field, pH, specific ions or enzyme.

    Schematic representation of thermally induced shape

    memory effect is given in Figure 10, where heating a

    sample above the switching transition temperature

    (T Trans) induces the recovery of the permanent shape of

    polymer. SMPs have the advantages of light weight, low

    cost, good processability, high shape deformability, high

    shape recoverability and tailorable switching tempera-

    ture.[143145] For example, poly(D,L-lactide) is a good shape

    memory biomaterial having good biodegradability and

    biocompatibility; and have been utilized for several tissue

    engineering applications. Zheng et al.[146] reinforced

    poly(D,L-lactide) (PDLLA) with hydroxylapatite for hard

    tissue engineering applications. The composite showed

    good biodegradation, biocompatibility and shape memory

    properties. The study showed that PDLLA/hydroxylapatite

    composites at a suitable fraction ratio of between 2.0:1 and

    2.5:1 had much higher shape recovery ratios and recover

    speed than pure PDLLA. By using a crystalline polymer as

    the fixing phase and a second crystalline polymer as the

    reversible phase, SMP blends were created for bioengineer-

    ing field. In that context, Behl et al. [147] reported binary

    biodegradable polymer blends from two crystalline poly-

    mers poly(p-dioxanone) (PPDO) and poly(caprolactone)

    with poly(alkylene adipate) mediator as a compatibilizer.

    The crystalline PPDO provides the hard segment to

    determinethepermanentshapeandthepoly(caprolactone)

    provides the soft segment to determine the switching

    temperature. Besides, Zhang et al.[148]

    introduced poly-(ethyleneglycol) dimethacrylate (PEGDMA) to PLGA/iso-

    phorone diisocyanate (IPDI). This system showed good

    shape memory and hydrophilic properties useful for

    biomedical applications. Further, Zhu et al.[149] improved

    the radiation efficiency of polycaprolactone by blending it

    with polymethylvinylsiloxane (PMVS)

    before radiation cross-linking, for biome-

    dical applications.

    4.12. Electro-responsive Polymers

    Electro-responsive polymers (ERPs) are

    very beneficial for biological applications

    because of their potential to being direc-

    tional, which can give rise to anisotropic

    deformation. ERPs can be used to prepare

    materials that swell, shrink, or bend in

    response to an electric field.[150,151] Since

    ERP can transform electrical energy into

    mechanical energy, they have promising

    applications in biomechanics, artificial

    muscle actuation, sensing, energy trans-

    duction, sound dampening, chemicalFigure 9. Illustration of shell cross-linking in drug -loaded polymer micelles and facili-tated drug release in response to cellular GSH.

    Figure 10. Schematic representation of the thermally inducedone-way shape-memory effect.

    302 Macromol. Biosci.2012, 12 , 286311

    2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.MaterialsViews.com

    www.mbs-journal.de

    R. Ravichandran, S. Sundarrajan, J. R. Venugopal, S. Mukherjee, S. Ramakrishna

  • 8/11/2019 Druk Advances in Polymeric Systems for Tissue Engineering and Biomedical Applications 2012 Macromolecular Bioscience

    18/26

    separations, and controlleddrug deliveryapplications.[150153]

    Geldeformation, which involves bending in an electric field

    is influenced by a number of factors like variable osmotic

    pressure based on the voltage-induced motions of ions in

    the solution, pH or salt concentration of the surrounding

    medium, position of the gel relative to the electrodes,thicknessorshapeofthegel,andtheappliedvoltage.[153,154]

    Transforming the application of an electric field into a

    physical response by a polymer generally results in certain

    changes in the properties of the polymer matrix like,

    collapse of a gel in an electric field, electrochemical

    reactions, electrically activated complex formation, ionic

    polymermetal interactions, electrorheological effects, or

    changes in electrophoretic mobility.[150] Typically, ERPs

    have been investigated in the form of polyelectrolyte

    hydrogels[150,151] which are capable of deformation under

    an electricfield dueto anisotropicswellingor deswelling, as

    charged ions are directed toward the anode or cathode

    sideofthegel.[150]Forexample,underanelectricfield,inthe

    case of hydrolyzed polyacrylamide gels, mobile H ions

    migrate toward the cathode while the negatively charged

    immobile acrylate groups in the polymer networks are

    attracted toward the anode, creating a uniaxial stress

    withinthegel.Theregionsurroundingtheanodeundergoes

    the greatest stress while the area in the vicinity of the

    cathode exhibits the smallest stress. This stress difference

    contributes to the anisotropic gel deformation under an

    electric field.[155] The natural polymers used to prepare

    electro-responsive materials include chitosan,[156] chon-

    droitin sulfate,[157] hyaluronic acid,[158] and alginate.[159]